Correlation Between ADC Therapeutics and PIRS Old
Can any of the company-specific risk be diversified away by investing in both ADC Therapeutics and PIRS Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ADC Therapeutics and PIRS Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ADC Therapeutics SA and PIRS Old, you can compare the effects of market volatilities on ADC Therapeutics and PIRS Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ADC Therapeutics with a short position of PIRS Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of ADC Therapeutics and PIRS Old.
Diversification Opportunities for ADC Therapeutics and PIRS Old
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ADC and PIRS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ADC Therapeutics SA and PIRS Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PIRS Old and ADC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ADC Therapeutics SA are associated (or correlated) with PIRS Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PIRS Old has no effect on the direction of ADC Therapeutics i.e., ADC Therapeutics and PIRS Old go up and down completely randomly.
Pair Corralation between ADC Therapeutics and PIRS Old
If you would invest 134.00 in ADC Therapeutics SA on May 11, 2025 and sell it today you would earn a total of 134.00 from holding ADC Therapeutics SA or generate 100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ADC Therapeutics SA vs. PIRS Old
Performance |
Timeline |
ADC Therapeutics |
PIRS Old |
Risk-Adjusted Performance
Weakest
Weak | Strong |
ADC Therapeutics and PIRS Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ADC Therapeutics and PIRS Old
The main advantage of trading using opposite ADC Therapeutics and PIRS Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ADC Therapeutics position performs unexpectedly, PIRS Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PIRS Old will offset losses from the drop in PIRS Old's long position.ADC Therapeutics vs. Q32 Bio | ADC Therapeutics vs. Nkarta Inc | ADC Therapeutics vs. Agios Pharm | ADC Therapeutics vs. Pliant Therapeutics |
PIRS Old vs. Adaptimmune Therapeutics Plc | PIRS Old vs. Mereo BioPharma Group | PIRS Old vs. PDS Biotechnology Corp | PIRS Old vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |